2027 Spring Meeting - Denver, CO
May 6 to 8, 2027
Registration
Save the date! May 6-8
The 2027 Spring Meeting is a 2.5 day conference focused on trending topics in IP law.
Venue:
Hyatt Regency Denver at the Convention Center
650 15th Street
Denver, CO 80202
RESERVATION LINK: To be provided
Hotel phone: 1-(303) 436-1234
HOTEL WEBSITE (not a reservation link)
Single/Double Room Rate: $259 plus applicable taxes (currently 15.75%) per night.
Reservation Cut-off - Tuesday, April 13, 2027.
Cancellation deadline - 72 hours prior to arrival.
NOTE: AIPLA does NOT engage any third party vendors to assist with room reservations. All room reservations should be made directly using the Reservation link above, or by contacting the Hyatt Regency Denver directly.
Tentative Leadership event schedule (times noted are Mountain Time):
May 4 - 2-5 PM - Executive Committee
May 5 - 10 AM - 12 Noon - Board Meeting
May 5 - 1 - 5 PM - Board and Committee Leadership Meeting
May 5 - 6-7:30 PM - Board and Committee Leadership Reception
May 8 - 12:30 - 4:00 PM - Board Meeting
Sponsorship & exhibitor opportunities information coming soon.
News
-
AIPLA Submits Comments on the World Intellectual Property Organization Riyadh Design Law Treaty
June 24, 2026
Alexandria, VA. June 11, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the World Intellectual Property Organization Riyadh Design Law Treaty. -
.png?sfvrsn=143e8f56_1 "supreme court")
AIPLA Files Amicus Brief in Arbutus Biopharma Corp. v. Moderna, Inc.
June 22, 2026
Arlington, VA. June 5, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief in Arbutus Biopharma Corp. v. Modernatx, Inc. -
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry. -
AIPLA Views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act”
June 3, 2026
Arlington, VA. June 3, 2026 – The American Intellectual Property Law Association (AIPLA) submitted a letter to the House Judiciary Committee’s Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet outlining its views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act.” -
AIPLA Submits Comments to the USPTO on 2026 Supplemental GUI Guidance
May 15, 2026
Arlington, VA. May 12, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on its Supplemental Guidance for Examination of Design Patent Applications Related to Computer-Generated Interfaces and Icons, issued on March 13, 2026.